参考文献

［1］林其德.重视妊娠合并自身免疫性疾病的诊治［J］.中国实用妇科与产科杂志，2010，26（6）：401-402.

［2］ML Seinen，NKH de Boer，ME van Hoorn，et al.Safe use of allopurinol and low-dose mercaptopurine therapy during pregnancy in an ulcerative colitis patient［J］.Inflammatory bowel diseases，2013，19（3）：E37.

［3］Kozenko M，Grynspan D，Oluyomi-Obi T，et al.Potential Teratogenic effects of allopurinol：a case report［J］.Am J Med Genet A，2011，155A：2247-2252.

［4］Argüelles-Arias F，Castro-Laria L，Barreiro-de Acosta M，et al.Is safety infliximab during pregnancy in patients with inflammatory bowel disease？［J］.Rev Esp Enferm Dig ，2012 ，104（2）：59-64.(https://www.daowen.com)

［5］Steenholdt C，Al-Khalaf M，Ainsworth MA，et al.Therapeutic infliximab drug level in a child born to a woman with ulcerative colitis treated until gestation week 31［J］.Journal of Crohn's colitis，2012，6（3）：358-361.

［6］Dozois E J，Wolff BG，Tremaine WJ，et al.Maternal and fetal outcome after colectomy for fulminant ulcerative colitis during pregnancy：case series and literature review［J］.Diseases of the colon and rectum，2006，49（1）：64-73.

［7］Bortoli A，Pedersen N，Duricova D，et al.pregnancy outcome in inflammatory bowel disease：prospective European case-control ECCO-EpiCom study［J］.Aliment Pharmacol Ther，2011，34（7）：724-734.